Regulator of calmodulin signaling knockout mice display anxiety-like behavior and motivational deficits

European Journal of Neuroscience

Volumn 35, Issue 2, 2012, Pages 300-308

  Davis, Maya M ^a   Olausson, Peter ^a   Greengard, Paul ^b   Taylor, Jane R ^a   Nairn, Angus C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Anxiety; Dopamine and cAMP regulated phosphoprotein; Motivation; Regulator of calmodulin signaling; Synapsin I

Indexed keywords

PHOSPHOPROTEIN; PHOSPHOPROTEIN DARPP 32; REGULATOR OF CALMODULIN SIGNALING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; EXPLORATORY BEHAVIOR; FEMALE; INSTRUMENTAL CONDITIONING; MALE; MAZE TEST; MOTIVATION; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; REINFORCEMENT; STIMULUS RESPONSE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CALMODULIN; CORPUS STRIATUM; IMMUNOBLOTTING; MICE; MICE, KNOCKOUT; MOTIVATION; NEURONS; PHOSPHOPROTEINS;

EID: 84855957321     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2011.07956.x     Document Type: Article

References (68)

1. Aberman, J.E. & Salamone, J.D. (1999) Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience, 92, 545-552.
2. Aberman, J.E., Ward, S.J. & Salamone, J.D. (1998) Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol. Biochem. Behav., 61, 341-348.
3. Baldwin, A.E., Sadeghian, K., Holahan, M.R. & Kelley, A.E. (2002) Appetitive instrumental learning is impaired by inhibition of cAMP-dependent protein kinase within the nucleus accumbens. Neurobiol. Learn. Mem., 77, 44-62.
4. Balleine, B. & Killcross, S. (1994) Effects of ibotenic acid lesions of the nucleus accumbens on instrumental action. Behav. Brain Res., 65, 181-193.
5. Bannerman, D.M., Deacon, R.M., Brady, S., Bruce, A., Sprengel, R., Seeburg, P.H. & Rawlins, J.N. (2004) A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors. Behav. Neurosci., 118, 643-647.
6. Barrot, M., Olivier, J.D.A., Perrotti, L.I., DiLeone, R.J., Berton, O., Eisch, A.J., Impey, S., Storm, D.R., Neve, R.L., Yin, J.C., Zachariou, V. & Nestler, E.J. (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc. Natl. Acad. Sci. USA, 99, 11435-11440.
7. Bredt, D.S. & Nicoll, R.A. (2003) AMPA receptor trafficking at excitatory synapses. Neuron, 40, 361-379.
8. Brené, S., Lindefors, N., Ehrlich, M., Taubes, T., Horiuchi, A., Kopp, J., Hall, H., Sedvall, G., Greengard, P. & Perssor, H. (1994) Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. J. Neurosci., 14, 985-998.
9. Corbit, L.H., Muir, J.L. & Balleine, B.W. (2001) The role of the nucleus accumbens in instrumental conditioning: evidence of a functional dissociation between accumbens core and shell. J. Neurosci., 21, 3251-3260.
10. Correa, M., Carlson, B.B., Wisniecki, A. & Salamone, J.D. (2002) Nucleus accumbens dopamine and work requirements on interval schedules. Behav. Brain Res., 137, 179-187.
11. Crombag, H.S., Sutton, J.M., Takamiya, K., Holland, P.C., Gallagher, M. & Huganir, R.L. (2008) A role for alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid GluR1 phosphorylation in the modulatory effects of appetitive reward cues on goal-directed behavior. Eur. J. Neurosci., 27, 3284-3291.
12. Czernik, A.J., Girault, J.A., Nairn, A.C., Chen, J., Snyder, G., Kebabian, J. & Greengard, P. (1991) Production of phosphorylation state-specific antibodies. Methods Enzymol., 201, 264-283.
13. Day, M., Wokosin, D., Plotkin, J.L., Tian, X. & Surmeier, D.J. (2008) Differential excitability and modulation of striatal medium spiny neuron dendrites. J. Neurosci., 28, 11603-11614.
14. Dinieri, J.A., Nemeth, C.L., Parsegian, A., Carle, T., Gurevich, V.V., Gurevich, E., Neve, R.L., Nestler, E.J. & Carlezon, W.A. Jr (2009) Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens. J. Neurosci., 29, 1855-1859.
15. Favilla, C., Abel, T. & Kelly, M.P. (2008) Chronic Gαs signaling in the striatum increases anxiety-related behaviors independent of developmental effects. J. Neurosci., 28, 13952-13956.
16. Flavell, S.W., Cowan, C.W., Kim, T.K., Greer, P.L., Lin, Y., Paradis, S., Griffith, E.C., Hu, L.S., Chen, C. & Greenberg, M.E. (2006) Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science, 311, 1008-1012.
17. Georgescu, D., Sears, R.M., Hommel, J.D., Barrot, M., Bolaños, C.A., Marsh, D.J., Bednarek, M.A., Bibb, J.A., Maratos-Flier, E., Nestler, E.J. & DiLeone, R.J. (2005) The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J. Neurosci., 25, 2933-2940.
18. Gourley, S.L., Kiraly, D.D., Howell, J.L., Olausson, P. & Taylor, J.R. (2008) Acute hippomcapus brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol. Psychiatry, 64, 884-890.
19. Gourley, S.L., Lee, A.S., Howell, J.L., Pittenger, C. & Taylor, J.R. (2010) Dissociable regulation of instrumental action withingh moouse prefrontal cortex. Eur. J. Neurosci., 32, 1726-1734.
20. Green, T.A., Alibhai, I.N., Hommel, J.D., DiLeone, R.J., Kumar, A., Theobald, D.E., Neve, R.L. & Nestler, E.J. (2006) Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J. Neurosci., 26, 8235-8242.
21. Hemmings, H.C. Jr & Greengard, P. (1986) DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J. Neurosci., 6, 1469-1481.
22. Hemmings, H.C. Jr, Girault, J.A., Williams, K.R., LoPresti, M.B. & Greengard, P. (1989a) ARPP-21, a cyclic AMP-regulated phosphoprotein (Mr=21, 000) enriched in dopamine-innervated brain regions. Amino acid sequence of the site phosphorylated by cyclic AMP in intact cells and kinetic studies of its phosphorylation in vitro. J. Biol. Chem., 264, 7726-7733.
23. Hemmings, H.C. Jr & Greengard, P. (1989b) ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Purification and characterization of the protein from bovine caudate nucleus. J. Neurosci., 9, 851-864.
24. Heyser, C.J., Fienberg, A.A., Greengard, P. & Gold, L.H. (2000) DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res., 867, 122-130.
25. Ito, R., Robbins, T.W., Pennartz, C.M. & Everitt, B.J. (2008) Functional interaction between the hippocampus and nucleus accumbens shell is necessary for the acquisition of appetitive spatial context conditioning. J. Neurosci., 28, 6950-6959.
26. Jentsch, J.D., Olausson, P., Nestler, E.J. & Taylor, J.R. (2002) Stimulation of protein kinase a activity in the rat amygdala enhances reward-related learning. Biol. Psychiatry, 52, 111-118.
27. Jovanovic, J.N., Benfenati, F., Siow, Y.L., Sihra, T.S., Sanghera, J.S., Pelech, S.L., Greengard, P. & Czernik, A.J. (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc. Natl. Acad. Sci. USA, 93, 3679-3683.
28. Jovanovic, J.N., Czernik, A.J., Fienberg, A.A., Greengard, P. & Sihra, T.S. (2000) Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat. Neurosci., 3, 323-329.
29. 2+-dependent glutamate release in isolated nerve terminals. J. Neurosci., 21, 7944-7953.
30. Kim, K.S., Lee, K.W., Baek, I.S., Lim, C.M., Krishnan, V., Lee, J.K., Nestler, E.J. & Han, P.L. (2008) Adenylyl cyclase-5 activity in the nucleus accumbens regulates anxiety-related behavior. J. Neurochem., 107, 105-115.
31. Kreitzer, A.C. & Malenka, R.C. (2007) Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models. Nature, 445, 643-647.
32. Lombroso, P.J., Naegele, J.R., Sharma, E. & Lerner, M. (1993) A protein tyrosine phosphatase expressed within dopaminoceptive neurons of the basal ganglia and related structures. J. Neurosci., 13, 3064-3074.
33. Lynch, W.J. & Taylor, J.R. (2005) Persistent changes in motivation to self-administer cocaine following modulation of cyclic AMP-dependent protein kinase A (PKA) activity in the nucleus accumbens. Eur. J. Neurosci., 22, 1214-1220.
34. Lynch, W.J., Kiraly, D.D., Caldarone, B.J., Picciotto, M.R. & Taylor, J.R. (2007) Effect of cocaine self-administration on striatal PKA-regulated signaling in male and female rats. Psychopharmacology (Berl.), 191, 263-271.
35. Maldonado-Irizarry, C.S., Swanson, C.J. & Kelley, A.E. (1995) Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J. Neurosci., 15, 6779-6788.
36. Malinow, R., & Malenka, R.C. (2002) AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci., 25, 103-126.
37. Masood, A., Nadeem, A., Mustafa, S.J. & O'Donnell, J.M. (2008) Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther., 326, 369-379.
38. Mead, A.N. & Stephens, D.N. (2003) Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice. J. Neurosci., 23, 1041-1048.
39. Meredith, G.E., Baldo, B.A., Andrezjewski, M.E. & Kelley, A.E. (2008) The structural basis for mapping behavior onto the ventral striatum and its subdivisions. Brain Struct. Funct., 213, 17-27.
40. Millan, M.J. (2003) The neurobiology and control of anxious states. Prog. Neurobiol., 7, 83-244.
41. Mingote, S., Weber, S.M., Ishiwari, K., Correa, M. & Salamone, J.D. (2005) Ratio and time requirements on operant schedules: effort-related effects of nucleus accumbens dopamine depletions. Eur. J. Neurosci., 21, 1749-1757.
42. Nestler, E.J. (2001) Molecular basis of long-term plasticity underlying addiction. Nat. Rev. Neurosci., 2, 119-128.
43. Nestler, E.J. & Carlezon, W.A. (2006) The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry, 59, 1151-1159.
44. Olausson, P., Jentsch, J.D., Tronson, N., Neve, R.L., Nestler, E.J. & Taylor, J.R. (2006) DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J. Neurosci., 26, 9196-9204.
45. Ouimet, C.C., Miller, P.E., Hemmings, H.C. Jr, Walaas, S.I. & Greengard, P. (1984) DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci., 4, 111-124.
46. Ouimet, C.C., Hemmings, H.C. & Greengard, P. (1989) ARRP-21, a cyclic AMP-regulation phosphoprotein enriched in dopamine-innervated brain regions. II. Immunocytochemical localization in rat brain. J. Neurosci., 9, 865-875.
47. Paine, T.A., Neve, R.L. & Carlezon, W.A. Jr (2009) Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology, 34, 2143-2155.
48. Pandey, S.C., Zhang, H., Ro, A. & Xu, T. (2005) Deficits in amygdaloid cAMP-responsive element-binding protein signaling play role in genetic predisposition to anxiety and alcoholism. J. Clin. Invest., 115, 2762-2773.
49. Parkinson, J.A., Dalley, J.W., Cardinal, R.N., Bamford, A., Fehnert, B., Lachenal, G., Rudarakanchana, N., Halkerston, K.M., Robbins, T.W. & Everitt, B.J. (2002) Nucleus accumbens dopamine depletion impairs both acquisition and performance of appetitive Pavlovian approach behaviour: implications for mesoaccumbens dopamine function. Behav. Brain Res., 137, 149-163.
50. Pellow, S. & File, S.E. (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav., 24, 525-529.
51. Pulipparacharuvil, S., Renthal, W., Hale, C.F., Taniguchi, M., Xiao, G., Kumar, A., Russo, S.J., Sikder, D., Dewey, C.M., Davis, M.M., Greengard, P., Nairn, A.C., Nestler, E.J. & Cowan, C.W. (2008) Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron, 59, 621-633.
52. Rakhilin, S.V., Olson, P.A., Nishi, A., Starkova, N.N., Fienberg, A.A., Nairn, A.C., Surmeier, D.J. & Greengard, P. (2004) A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science, 306, 698-701.
53. Risinger, F.O., Freeman, P.A., Greengard, P. & Fienberg, A.A. (2001) Motivational effects of ethanol in DARPP-32 knock-out mice. J. Neurosci., 21, 838-842.
54. Schmitt, U. & Hiemke, C. (1998) Combination of open field and elevated plus-maze: a suitable test battery to assess strain as well as treatment differences in rat behavior. Prog. Neuropsychopharmacol. Biol. Psychiatry, 22, 1197-1215.
55. Sears, R.M., Liu, R.J., Narayanan, N.S., Sharf, R., Yeckel, M.F., Laubach, M., Aghajanian, G.K. & DiLeone, R.J. (2010) Regulation of nucleus accumbens activity by the hypothalamic neuropeptide melanin-concentrating hormone. J. Neurosci., 30, 8263-8273.
56. Sihra, T.S., Wang, J.K., Gorelick, F.S. & Greengard, P. (1989) Translocation of synapsin I in response to depolarization of isolated nerve terminals. Proc. Natl. Acad. Sci. USA, 86, 8108-8112.
57. Silvestre, J.S., Fernández, A.G. & Palacios, J.M. (1999) Effects of rolipram on the elevated plus-maze test in rats: a preliminary study. J. Psychopharmacol., 13, 274-277.
58. Stipanovich, A., Valjent, E., Matamales, M., Nishi, A., Ahn, J.-H., Maroteaux, M., Bertran-Gonzalez, J., Brami-Cherrier, K., Enslen, H., Corbillé, A.-G., Filhol, O., Nairn, A.C., Greengard, P., Hervé, D. & Girault, J.-A. (2008) A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature, 453, 879-884.
59. Surmeier, D.J., Shen, W., Day, M., Gertler, T., Chan, S., Tian, X. & Plotkin, J.L. (2010) The role of dopamine in modulating the structure and function of striatal circuits. Prog. Brain Res., 183, 149-167.
60. Svenningsson, P., Tzavara, E.T., Witkin, J.M., Fienberg, A.A., Nomikos, G.G. & Greengard, P. (2002) Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc. Natl Acad. Sci. USA, 99, 3182-3187.
61. Svenningsson, P., Nairn, A.C. & Greengard, P. (2005) DARPP-32 mediates the actions of multiple drugs of abuse. AAPS J., 7, E353-E360.
62. Taverna, S., Ilijic, E. & Surmeier, D.J. (2008) Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J. Neurosci., 28, 5504-5512.
63. Valverde, O., Mantamadiotis, T., Torrecilla, M., Ugedo, L., Pineda, J., Bleckmann, S., Gass, P., Kretz, O., Mitchell, J.M., Schütz, G. & Maldonado, R. (2004) Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology, 29, 1122-1133.
64. Walaas, S.I. & Greengard, P. (1984) DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J. Neurosci., 4, 84-98.
65. Yin, H.H. & Lovinger, D.M. (2006) Frequency-specific and D2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling. Proc. Natl. Acad. Sci. USA, 103, 8251-8256.
66. Zachariou, V., Benoit-Marand, M., Allen, P.B., Ingrassia, P., Fienberg, A.A., Gonon, F., Greengard, P. & Picciotto, M.R. (2002) Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1. Biol. Psychiatry, 51, 612-620.
67. Zachariou, V., Sgambato-Faure, V., Sasaki, T., Svenningsson, P., Berton, O., Fienberg, A.A., Nairn, A.C., Greengard, P. & Nestler, E.J. (2006) Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Neuropsychopharmacology, 31, 555-562.
68. Zhang, H.T., Huang, Y., Masood, A., Stolinski, L.R., Li, Y., Zhang, L., Dlaboga, D., Jin, S.L., Conti, M. & O'Donnell, J.M. (2008) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychopharmacology, 33, 1611-1623.